Noting the rapid blood clearance of anti-CSPG4 IgE based on the biodistribution and imaging data in tumor-bearing mice, we suspected that the first imaging and ex vivo biodistribution measurements taken at 4 h were too late to provide an accurate estimate of the true half-life of the early clearance phase and instead overestimated the half-life. This evidence concerns the gene IGHE and neoplasm.